4th International Conference on Hypertension & Healthcare
This format has proven to be extremely popular with Clinicians and researchers, Heads, Deans and Professors of Hypertension or Cardiology departments. I do hope you will mark this date in your calendar, check the website for updates and join us in Zurich for what promises to be another exciting, cutting edge exploration of the latest advances in hypertension and cardiovascular diseases.
Theme of the conference: Control Hypertension: Add life to Longevity
For more details of the conference please have a glance at our website: https://hypertension.conferenceseries.com/
High Blood Pressure and Kidney Diseases
Hypertension & Stroke
Hypertension and Diabetes
Hypertensive Heart Disease
Evaluation of Hypertension
Causative Factors, Risk Assessment and Complications
Diagnosis and Pathophysiology of Hypertension
Anti- Hypertensive Medications
Hypertension Therapy Devices
Diet and lifestyle in Hypertension Management
Nursing Management of Hypertension
Advanced Treatment Approaches
Clinical Trials and Case Reports
For Abstract submission please visit the link :https://hypertension.conferenceseries.com/abstract-submission.php
We look forward to welcoming you to Zurich!
Conference Series LLC through its Open Access Initiative is committed to create real and reliable contributions to the scientific community. Conference Series Ltd organize 600+ Conferences once a year across USA, Europe & Asia with support from a thousand additional scientific societies and Publishes 400+ Open access journals that contains over 30000 eminent personalities, putative scientists as editorial board members.
Kemp House, 152 City Road, London EC1V 2NX
Phone No: +44-8000148923
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 4th International Conference on Hypertension & Healthcare here
News-ID: 922502 • Views: 139
More Releases from Conference Series Ltd
4th European Biopharma Congress
Biopharmaceuticals Conference Series Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria. The opportunity in biopharmaceuticals is big and growing too
20th European Cardiology Conference
Euro Cardiology 2017 invites all the cardiologists, Scientists, Professors, Research scholars, Industrial Professionals, Cardiac surgeons at 20th European Cardiology Conference is going to be held in Budapest, Hungary during October 16-18, 2017. With the support of Euro Cardiology 2016 Organizing Committee Members, the CME accredited 20th European Cardiology Conference is scheduled to be held in Budapest, Hungary during October 16-18, 2017. Cardiology Conferences will lay a platform for world-class professors, cardiologists
22nd World Cardiology Conference
World Cardiology 2017 22nd World Cardiology Conference December 11-12, Rome, Italy Accelerating Innovations & fostering advances in Cardio Research With the success of “16th World Cardiology Congress” in Dubai, World Cardiology Team is proud to host upcoming “22nd World Cardiology Conference” during December 11-12, 2017 Rome, Italy. The event will bring together world-class cardiologists, researchers and professors to discuss strategies for prevention of coronary disease, stroke and sudden death. World Cardiology Conference 2017
More Releases for Hypertension
Global Pulmonary Arterial Hypertension Market to 2024
Global Pulmonary Arterial Hypertension (PAH) market was valued at $5.0bn in 2015 and is forecast to grow at a modest 6.0% CAGR between 2015 and 2024, to result in 2024 global sales of $9.0bn. PAH is broadly split into two classes, primary or secondary. Primary pulmonary hypertension (PPH) refers to pulmonary hypertension occurring without an identifiable cause. Secondary pulmonary arterial hypertension (PAH) occurs in association with some other identifiable medical condition.
Hypertension: Often unnoticed, always a risk
Vital mushrooms provide a valuable contribution in the prevention and therapy of hypertension Hypertension is considered one of the greatest health problems of the modern age. In the United Kingdom alone, according to data from the NHS, about 12,5 million people - almost every fourth - are affected. The great danger: Although hypertension can cause further serious diseases, many sufferers do not suspect their hypertension. They feel well and have
H2 2017 Pulmonary Arterial Hypertension - Pipeline Review
"The Report Pulmonary Arterial Hypertension - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertension - Pipeline Review, H2 2017, provides an overview of the Pulmonary Arterial Hypertension (Cardiovascular) pipeline landscape. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the
Ocular Hypertension - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H1 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous
Renal Hypertension: Diagnosis & Treatment
“Hypertension & Cardiovascular disease after Kidney Transplantation” is one of the workshops to be conducted by Dr. Hossein Tabriziani of Loma Linda University, USA under the session ‘Renal Hypertension’ at the meeting 2nd International Conference on Hypertension & Healthcare which is going to be held at Amsterdam, Netherlands during September 11-13, 2017. High blood pressure is a leading cause of kidney disease and kidney failure ESRD (end stage renal disease). Hypertension
Pulmonary Arterial Hypertension - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Arterial Hypertension - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertension - Pipeline Review, H1 2017, provides an overview of the Pulmonary Arterial Hypertension (Cardiovascular) pipeline landscape. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the right